Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00535119
Recruitment Status : Completed
First Posted : September 26, 2007
Last Update Posted : May 22, 2015
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2012
  Study Completion Date : No date given